Omada launches GLP-1 Flex Care offering for employers, expanding its metabolic and chronic care portfolio

 

Omada Health posts first GAAP-profitable quarter, 2025 revenue up 53% to $260M, issues prudent 2026 growth guide

• Revenue grew 53% in 2025 to $260M, far above initial post-IPO expectations.
• Q4 delivered first GAAP net income ($5M) and record 73% adjusted margins, reflecting strong expansion and earlier-than-expected profitability.
• Q4 revenue rose 58% year over year to $76M, per reported financial results.
• Q4 non-GAAP EPS was $0.08, above analyst estimates alongside stronger-than-expected revenue performance.
• Members rose 55% to 886,000, with covered lives exceeding 25M and <10% penetration.
• GLP-1 care track now supports 150k+ members, driving strong cardiometabolic and multi-condition growth.
• Company launched GLP-1 Flex Care offering for employers, expanding its metabolic and chronic care portfolio.
https://finviz.com/quote.ashx?t=OMDA&p=d